Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901

Thomas Shea, Jeffrey Johnson, Peter Westervelt, Sherif Farag, John McCarty, Asad Bashey, Luis Isola, Lee Anne Baxter-Lowe, Michael Kelly, Kouros Owzar, Charles Linker

Research output: Contribution to journalArticle

51 Scopus citations

Fingerprint Dive into the research topics of 'Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901'. Together they form a unique fingerprint.

Medicine & Life Sciences